TARS Net Income Growth
49.48%TTM
Period ending:
TARS TTM Net Income YoY %%
183.62%-1155.69%
2020-12-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
TARS net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 23 observations from Dec 31, 2020 to Jun 30, 2026.
| Period ending | Net Income Growth |
|---|---|
| 49.4788% | |
| 54.0084% | |
| 42.5221% | |
| 39.589% | |
| 38.7003% | |
| 29.1906% | |
| 14.9669% | |
| -24.8657% | |
| -64.9984% | |
| -127.0575% | |
| -118.861% | |
| -69.853% | |
| -60.8962% | |
| -46.7215% | |
| -344.6824% | |
| -498.7617% | |
| -1,026.0757% | |
| -205.3538% | |
| 47.9226% | |
| 36.8682% | |
| 31.2329% | |
| -232.6446% | |
| -874.0963% |
Compare net income growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) net income growth
- Ensign Group Inc (ENSG) net income growth
- Krystal Biotech Inc (KRYS) net income growth
- Protagonist Therapeutics Inc (PTGX) net income growth
- Tg Therapeutics Inc (TGTX) net income growth
- Healthequity Inc (HQY) net income growth
- Pacs Group Inc (PACS) net income growth
- Alkermes (ALKS) net income growth
Compare all covered stocks by net income growth →
All TARS financial metrics · TARS stock overview · How to interpret financial metrics
